China SXT Pharmaceuticals Inc (SXTC)
NASDAQ
Fin d'année 31 Mars 2024 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | 31.026 | 12.249 | -52.526 | -9.771 | -16.847 | -18.811 | -11.765 |
Return on Equity (%) | 72.307 | 21.384 | -100.327 | -21.67 | -35.423 | -38.148 | -21.655 |
Return on Invested Capital (%) | 73.032 | 21.205 | -11.825 | -24.488 | -81.103 | -85.92 | -35.329 |
Operating Margin (%) | 23.208 | 25.613 | -134.986 | -27.731 | -206.418 | -276.775 | -132.521 |
Net Profit Margin (%) | 16.925 | 21.948 | -199.303 | -57.514 | -220.446 | -300.963 | -160.737 |
Book Value Per Share | 0.161 | 0.487 | 0.27 | 1.025 | 8.068 | 1.282 | 6.272 |
Earnings Per Share | 0.059 | 0.068 | -0.297 | -0.177 | -2.824 | -0.519 | -1.397 |
Cash Per Share | 0.028 | 0.402 | 0.21 | 0.859 | 7.644 | 1.519 | 5.442 |
Working Capital Per Share | 0.087 | 0.408 | 0.213 | 0.3 | 2.625 | 0.439 | 2.404 |
Operating Profit Per Share | 0.17 | 0.203 | 0.078 | 0.183 | 0.616 | 0.037 | 0.249 |
EBIT Per Share | 0.081 | 0.079 | -0.3 | -0.189 | -2.663 | -0.519 | -1.397 |
EBITDA Per Share | 0.081 | 0.079 | -0.3 | -0.189 | -2.663 | -0.519 | -1.397 |
Free Cash Flow Per Share | 0.106 | 0.087 | -0.295 | -0.193 | -2.951 | -0.535 | -1.486 |
Fin d'année 31 Mars 2024 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 20M | 22,71M | 34,67M | 15,53M | 2,03M | 11,43M | 2,22M |
Fin d'année 31 Mars 2024 | |||||||
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | ||||||
Return on Assets (%) | N/A | ||||||
Return on Equity (%) | N/A | ||||||
Return on Invested Capital (%) | N/A | ||||||
Operating Margin (%) | N/A | ||||||
Net Profit Margin (%) | N/A | ||||||
Sales Per Share | N/A | ||||||
Book Value Per Share | N/A | ||||||
Earnings Per Share | N/A | ||||||
Cash Per Share | N/A | ||||||
Working Capital Per Share | N/A | ||||||
Operating Profit Per Share | N/A | ||||||
EBIT Per Share | N/A | ||||||
EBITDA Per Share | N/A | ||||||
Free Cash Flow Per Share | N/A | ||||||
Current Ratio | N/A | ||||||
Quick Ratio | N/A | ||||||
Inventory Turnover (Days) | N/A |
Capitalisation boursière | 1,43M |
Ratio cours/bénéfice | -0,46 |
Ratio prix/ventes | 0,74 |
Ratio prix/liquidités | 0,12 |
Ratio prix/valeur comptable | 0,1 |
Rendement de dividende | - |
Actions en circulation | 3,48M |
Volume moyen (1 semaine) | 256,18k |
Volume moyen (1 mois) | 1,63M |
Variation sur 52 semaines | -77,22% |
Plus haut sur 52 semaines | 3,37 |
Plus bas sur 52 semaines | 0,30 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales